Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1Emanuele Criscuolo, Maria Laura De Sciscio, Angela De Cristofaro, et al.
Lipids in Health and Disease|September 13, 2003
Endocannabinoid signalling in the blood of patients with schizophreniaNicola De Marchi, Luciano De Petrocellis, Pierangelo Orlando, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 15, 2003
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brainDaniela Viganò, Maria Grazia Cascio, Tiziana Rubino, et al.
Brain Research|October 24, 2002
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaineSara González, Maria Grazia Cascio, Javier Fernández-Ruiz, et al.
Biochimie|January 26, 2010
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid systemDaniele Amadio, Filomena Fezza, Giuseppina Catanzaro, et al.
Biochimica Et Biophysica Acta|July 5, 2003
Endocannabinoids and related fatty acid amides, and their regulation, in the salivary glands of the lone star tickFilomena Fezza, Jack W Dillwith, Tiziana Bisogno, et al.
Cellular and Molecular Life Sciences : CMLS|January 9, 2013
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than twoElisa Bisicchia, Valerio Chiurchiù, Maria Teresa Viscomi, et al.
Journal of Neurochemistry|January 11, 2011
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptorSergio Oddi, Enrico Dainese, Filomena Fezza, et al.
Journal of Lipid Research|May 8, 2010
Pitfalls and solutions in assaying anandamide transport in cellsSergio Oddi, Filomena Fezza, Giuseppina Catanzaro, et al.
Pageof 7